The F.D.A. made the product review a priority, citing shortages that occurred in the wake of several recalls of drugs that were found to contain potentially cancer-causing chemicals.
from Health https://ift.tt/2u2kptB
Subscribe to:
Post Comments (Atom)
Rose
0 comments:
Post a Comment